Literature DB >> 6296424

Transcription of herpes simplex virus genes in vivo: overlap of a late promoter with the 3' end of the early thymidine kinase gene.

J A Sharp, M J Wagner, W C Summers.   

Abstract

We identified in herpes simplex virus type 1-infected cells six cytoplasmic transcripts which were complementary to BamHI restriction endonuclease fragment Q. Two transcripts appeared in major amounts compared with the other four. One major transcript of about 1.4 kilobases was the mRNA for the viral thymidine kinase, was synthesized at intermediate times, and was classified as a beta transcript. The other major transcript was synthesized at late times and was classified as a gamma transcript. This late transcript was about 3 kilonucleotides long and was transcribed in the same direction as the gene for thymidine kinase. The 5' end of this late RNA was located by RNA sequence analysis and was 23 nucleotides downstream from the polyadenylation site for the thymidine kinase mRNA. This finding led to the conclusion that the control region for the 3-kilobase gamma transcript is contained within the 3' untranslated region of the thymidine kinase transcript.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6296424      PMCID: PMC256381     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  A restriction fragment analysis of the T7 left-early region.

Authors:  R A Ludwig; W C Summers
Journal:  Virology       Date:  1975-12       Impact factor: 3.616

2.  Characterization of the mRNA for herpes simplex virus thymidine kinase by cell-free synthesis of active enzyme.

Authors:  K Cremer; M Bodemer; W C Summers
Journal:  Nucleic Acids Res       Date:  1978-07       Impact factor: 16.971

3.  Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids.

Authors:  A J Berk; P A Sharp
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

4.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

5.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

6.  Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins.

Authors:  R W Honess; B Roizman
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

7.  Secondary structure maps of ribosomal RNA. II. Processing of mouse L-cell ribosomal RNA and variations in the processing pathway.

Authors:  P K Wellauer; I B Dawid; D E Kelley; R P Perry
Journal:  J Mol Biol       Date:  1974-10-25       Impact factor: 5.469

8.  Preparation and preliminary characterization of purified ovalbumin messenger RNA from the hen oviduct.

Authors:  J M Rosen; S L Woo; J W Holder; A R Means; B W O'Malley
Journal:  Biochemistry       Date:  1975-01-14       Impact factor: 3.162

9.  Rapid sequence determination of late simian virus 40 16S mRNA leader by using inhibitors of reverse transcriptase.

Authors:  M Bina-Stein; M Thoren; N Salzman; J A Thomspon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

10.  Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.

Authors:  G K McMaster; G G Carmichael
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

View more
  22 in total

1.  Mutational analysis of two herpes simplex virus type 1 late promoters.

Authors:  K R Steffy; J P Weir
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

2.  Upstream promoter elements of the herpes simplex virus type 1 glycoprotein H gene.

Authors:  K R Steffy; J P Weir
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

3.  Control of mRNA stability by the virion host shutoff function of herpes simplex virus.

Authors:  A A Oroskar; G S Read
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

4.  DNA sequence of the herpes simplex virus type 1 gene encoding glycoprotein gH, and identification of homologues in the genomes of varicella-zoster virus and Epstein-Barr virus.

Authors:  D J McGeoch; A J Davison
Journal:  Nucleic Acids Res       Date:  1986-05-27       Impact factor: 16.971

5.  Isolation and characterization of PRT1, a gene required for the initiation of protein biosynthesis in Saccharomyces cerevisiae.

Authors:  C Keierleber; M Wittekind; S L Qin; C S McLaughlin
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

6.  The promoter for the late gene encoding Vp5 of herpes simplex virus type 1 is recognized by cell extracts derived from uninfected cells.

Authors:  G E Chisholm; W C Summers
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

7.  Transcriptional targeting of herpes simplex virus for cell-specific replication.

Authors:  S Miyatake; A Iyer; R L Martuza; S D Rabkin
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

8.  Regulation of herpes simplex virus thymidine kinase in cells treated with a synergistic antiviral combination of alpha interferon and acyclovir.

Authors:  J L Taylor; P Tom; J Guy; R M Selvarajan; W J O'Brien
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

9.  Herpes simplex virus transactivator ICP4 operationally substitutes for the cellular transcription factor Sp1 for efficient expression of the viral thymidine kinase gene.

Authors:  A N Imbalzano; D M Coen; N A DeLuca
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

10.  Identification and nucleotide sequence of a gene in feline herpesvirus type 1 homologous to the herpes simplex virus gene encoding the glycoprotein H.

Authors:  K Maeda; Y Kawaguchi; N Kamiya; M Ono; Y Tohya; C Kai; T Mikami
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.